APCO has appointed South Africa-based Infinitum Global Health (IGH) as its regional partner to spearhead the distribution of two health supplement innovations across Africa, the Middle East, and America. The products are designed to promote anti-aging and rejuvenation while supporting individuals living with HIV/AIDS and cancer through stem cell activation to improve immunity for symptoms remedy. APCO is confidence in the products’ efficacy, citing internationally recognized research and a strong safety profile with no reported side effects.
Professor Dr. Pichaet Wiriyachitra, Chief Executive Officer of Asian Phytoceuticals Public Company Limited (SET: APCO), a fully integrated natural health and beauty innovation company, stated that the partnership agreement with Mrs. Leonor Bosman from Infinitum Global Health (IGH), which has strong network to facilitate this operation marks a strategic step in expanding APCO’s global footprint. The collaboration aims to enhance quality of life through advanced health innovations focusing on anti-aging solutions alongside providing solutions for HIV/AIDS and cancer patients.
The two flagship products set for international distribution are mylife100, formulated for anti-aging and cancer management, and KTCEL, designed to address cancer and HIV/AIDS while promoting rejuvenation. Both formulations are derived from fortified mangosteen extracts, developed to strengthen immune responses and stimulate stem cell activity at both mesenchymal and hematopoietic levels. These innovations support the body’s natural regeneration processes and are designed to target HIV and cancer cells without affecting healthy cells. Additionally, they contribute to reverse aging and restoring physical vitality, making them suitable for preventive healthcare and improving patients’ overall quality of life.
Both products have undergone consumer testing and received positive market feedback in the dietary supplement sector. They have also gained recognition from international research institutions, supported by proprietary studies published in the U.S.-based academic journals Clinical Immunology & Research and Food Science and Nutrition. The mylife100 formula enhances stem cell activation to promote rejuvenation while boosting immunity against cancer, while KTCEL stimulates stem cell function to generate Killer T Cells targeting cancer and HIV/AIDS, alongside anti-aging benefits.
Infinitum Global Health (IGH) is preparing to roll out KTCEL across Africa, a continent with a population exceeding 1.4 billion people, including more than 26 million individuals living with HIV/AIDS and over 1 million new cancer cases annually. The partnership agreement spans 5 years, with product shipments from APCO scheduled to commence on July 1, 2026 with plans to further expand into the Middle East and the Americas in subsequent phases.
“This collaboration represents a significant opportunity to expand into international markets while advancing Thai-developed health innovations on a global scale, with fortified mangosteen extracts holding strong potential to enhance the quality of life for people worldwide.” said Professor Dr. Pichaet
